CLAiR
Toku Eyes
CE markedcardiovascular riskoculomics
Reads a standard retinal photo to estimate cardiovascular disease risk during a routine eye exam. Toku also sells BioAge and has MyKidneyAI in development.
US: FDA Breakthrough designation only, not clearance.
- Company
- Toku Eyes
- Category
- Other
- Reads
- Color retinal images from existing fundus cameras
- Built for
- Optometrists and ophthalmologists, cardiovascular risk programs
- Billing
- Check vendor
- Regulatory
- CE and UKCA marks (Feb 2024). In the US it holds FDA Breakthrough Device designation (Nov 2023), which is not clearance or authorization. CLAiR is not listed on the Toku homepage fetched on the verification date. · source
- Last verified
- 2026-10-07
DotAEye is independent of Toku Eyes. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.